› $4.85 Billion settlement in drug case
› 12.03.2008 — Follow-up to Canadian BART study confirms Trasylol risks › more
A conclusive study of Bayer AG’s aprotinin injection Trasylol uncovered a grim fact: one out of every 50 Trasylol recipients dies. The study was conducted in Canada and involved monitoring the health of 2,331 high-risk heart patients.
Read the rest of this entry »
Beasley Allen Law Firm 218 Commerce Street Montgomery, AL 36104 Tel +1-800-898-2034 Fax +1-334-954-7555 client.support@beasleyallen.com
Google Maps
